Bristol Myers Squibb today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients with symptomatic New York Heart Association (NYHA) class II-III ...

Scientists have designed new drug frameworks that selectively target CYP3A4, one of the most critical CYP proteins.

Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted full approval for VITRAKVI® (larotrectinib), a first-in-class TRK inhibitor for the treatment of adult and pediatric ...

Iowa pharmacists say that they could do more to control your prescription drug costs if lawmakers pass reforms impacting pharmacy benefit managers this session. PBMs work with insurers, employers, and ...

And what about grapefruit juice versus chunks of the actual fruit? Below, we break down everything you need to know ...

Brian Tait, Chief Scientific Officer at Haplomic Technologies Pty Ltd, focuses here on CYP genes, haplotypes, and their ...

Naldemedine was safe and effective and reduced health care resource utilization among adults with opioid-induced constipation and chronic noncancer pain.

Artificial intelligence (AI) has taken the biotech industry by storm, allowing companies to speed up the drug discovery process while also making it more cost-effective. With so many companies in the ...

They also regulate blood pressure, help make red blood cells, and are involved with keeping your bones healthy. Some drugs are known as nephrotoxic, which means that their effects can cause damage to ...